Search
for
Sort by
Research 421–450 of 1000+
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- The Evolving Global Burden of Alopecia Areata in Young Adults: High-Income Nations Bear the Greatest Impact
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- 0150 Single-cell and spatial transcriptome profiling reveals innate-adaptive crosstalk in alopecia areata
- Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Lasers in the management of alopecia: a review of established therapies and advances in treatment
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Diagnosis and differential diagnosis of tertiary androgenetic alopecia with severe alopecia areata based on high‐resolution MRI
- DERMOSCOPIC FEATURES IN CICATRICIAL AND NON CICATRICIAL ALOPECIA
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- The role of the skin microbiome in the development of alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- 526 Gut dysbiosis in alopecia areata patients reveals overabundance of firmicutes and under representation of bacteroides
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- Trichoscopic findings in patients with patchy alopecia and its comparison with histopathological diagnosis
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Novel drugs of United States Food and Drug Administration approved in 2024
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- Lymphocytes, neuropeptides, and genes involved in alopecia areata